Regional CBF changes in Parkinson's disease: A correlation with motor dysfunction

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 9, 2007, Pages 1458-1466

  Hsu, Jung Lung ^a,b,c   Jung, Tzyy Ping ^c,d   Hsu, Chien Yeh ^b   Hsu, Wei Chih ^a   Chen, Yen Kung ^a   Duann, Jeng Ren ^c,d   Wang, Han Cheng ^a   Makeig, Scott ^c,d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Independent component analysis; Parkinson's disease; Regional cerebral blood flow; SPECT; Statistical parametric mapping

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN PERFUSION; BRAIN REGION; BRAIN STEM; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; INDEPENDENT COMPONENT ANALYSIS; INSULA; LOGISTIC REGRESSION ANALYSIS; MALE; MOTOR DYSFUNCTION; OCCIPITAL CORTEX; PARIETAL LOBE; PARKINSON DISEASE; PREFRONTAL CORTEX; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; TEMPORAL CORTEX; THALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; CEREBROVASCULAR CIRCULATION; FEMALE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548172718     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0360-7     Document Type: Article

References (40)

1. Hornykiewcz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966;18:925-64.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-75.
3. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-71.
4. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;32:181-5.
5. Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985;35:1127-34.
6. Henriksen L, Boas J. Regional cerebral blood flow in hemiparkinsonian patients: emission computerized tompgraphy of inhaled 133Xenon before and after levodopa. Acta Neurol Scand 1985;71:257-66.
7. Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1985;35:1399-405.
8. 99mTc-HMPAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab 1988;8(suppl):S101-8.
9. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40;1583-9.
10. Vaasinen V, Maguire RP, Hundemer HP, Leenders KL. Corticostriatal covariance patterns of 6-[F18]fluoro-L-dopa and [F18]fluorodeoxyglucose PET in Parkinson's disease. J Neurol 2006;253:340-8.
11. Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, et al. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol 2004;251:1383-92.
12. Bell AJ, Sejnowski TJ. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 1995;7(6):1129-59.
13. Jung T-P, Makeig S, McKeown MJ, Bell AJ, Lee T-W, Sejnowski TJ. Imaging brain dynamics using independent component analysis. Proc IEEE 2001;89:1107-22.
14. McKeown MJ, Makeig S, Brown GG, Jung T-P, Kindermann SS, Sejnowski TJ. Analysis of fMRI by blind separation into independent spatial components. Hum Brain Mapp 1988:6:160-88.
15. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-9.
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
17. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease and movement disorders. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease vol 2. Florham Park: NJ Mcmillan Health Care Information; 1987. pp. 153-64.
18. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-43.
19. Duann JR, Jung TP, Kuo WJ, Yeh TC, Makeig S, Hsieh JC, et al. Single-trial variability in event-related BOLD signals. Neuroimage 2002;15:823-35.
20. Makeig S, Jung TP, Bell AJ, Ghahremani D, Sejnowski TJ. Blind separation of auditory event-related brain responses into independent components. Proc Natl Acad Sci USA 1997;94:10979-84.
21. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690-9.
22. Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994;1:214-20.
23. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29-36.
24. Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-61.
25. Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, et al. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain 2005;128:570-83.
26. Antonini A, Vontobel P, Psylla M, Gunther I, Maguire PR, Missimer J, et al. Complememtary positron emsission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol 1995;52:1183-90.
27. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004;24:7-16.
28. Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, et al. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study. Mov Disord 2002;17:782-8.
29. Goerendt IK, Lawrence AD, Mehta MA, Stern JS, Odin P, Brooks DJ. Distributed neural actions of anti-parkinsonian therapies as revealed by PET. J Neural Transm 2006;113:75-86.
30. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708-15.
31. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309-19.
32. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:47-8.
33. Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, et al. Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure. J Neurol Sci 1999;163:119-26.
34. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
35. 18F]FDG-PET. Mov Disord 2001;16:1014-22.
36. Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 2005;30:590-601.
37. Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MT, Passeri A, Martini S, et al. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. J Nucl Med 2002;43:725-32.
38. Lozza C, Marie RM, Baron JC. The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease. Neuroimage 2002;17:688-99.
39. Nagano-Saito A, Kato T, Arahata Y, Washimi Y, Nakamura A, Abe Y, et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 2004;22:553-61.
40. Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease. J Neurol Sci 2006;241:67-72.